Pressure Biosciences Inc
PBIODelisted- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000830656
Pressure Biosciences Inc was delisted in 2024; its insiders filed their last Form 4 on Sep 30, 2024; no institution reported holding it in 13F filings for Q2 2024; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 0
- Q2 2024
- 13F value
- $0
- Reported value at the end of Q2 2024
- Superinvestors holding
- 0
- At the end of Q2 2024
Superinvestors holding PBIO, Q2 2024
No superinvestor reported holding PBIO at the end of Q2 2024.
Latest insider trades
Open-market purchases and sales by Pressure Biosciences Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 (view filing) | Sep 14 | 2 days | Peterson Jeffrey NDirector | PPurchase | +90.4K | $2.50 | +$113.0K | –45.2K after | Derivative2 lots |
| Sep 16, 2021 (view filing) | Sep 14 | 2 days | Lazarev Alexander VVP of Research & Development | PPurchase | +52.9K | $2.50 | +$66.3K | –26.5K after | Derivative2 lots |
| Sep 16, 2021 (view filing) | Sep 14 | 2 days | Schumacher Richard TPresident, CEO | PPurchase | +46.6K | $2.50 | +$58.3K | –23.3K after | Derivative2 lots |
Top 10 13F holders, Q2 2024
The largest institutional positions in Pressure Biosciences Inc at the end of Q2 2024; share changes are against Q1 2024.
No institution reported holding PBIO in 13F filings for Q2 2024.